Parkinson's Disease Trial, Recruiting NCT06416345 Sponsor: Amsterdam UMC, location VUmc Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06416345
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Parkinson's disease using a specific set of standard diagnostic guidelines called the UK Brain Bank criteria
  • People who experience freezing of gait (sudden, temporary inability to move the feet while walking) every day
  • People whose Parkinson's disease is at a moderate to moderately advanced stage (rated between stage 2 and 4 on a standard scale used by doctors)
  • People whose Parkinson's medications and/or deep brain stimulation device settings have been considered stable by their treating neurologist
  • People who are able to walk for 5 minutes without physical help from another person

Who may not be able to join:

  • People who are currently taking part in another clinical study
  • People who already use a personal cueing device at home to help with walking
  • People who have previously used a specific medical device called the Cue2Walk
  • People who have other health conditions that would make participation in the trial difficult (confirm with trial site)
  • People whose cognitive (thinking and memory) difficulties make it hard to understand and follow the instructions involved in the treatment, as measured by a standard memory and thinking test with a score below 16

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Erwin EH van Wegen, PhD, Amsterdam UMC, location VUmc

Phone: 020-4440461

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Amsterdam UMC, location VUmc
Registry
ClinicalTrials.gov
Start date
22 August 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Self-reported quality of life; General health-related quality of life; Time in Freezing of Gait

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov